|
|
|
|
Age Related Macular Degeneration Clinical Trial: Reports summarize age related macular degeneration clinical trial study results from United BioSource Corporation
Age Related Macular Degeneration Clinical Trial Data detailed in 'Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration' have been presented.In this...
|
|
|
Physician's Focus: Age-Related Macular Degeneration (AMD)-Risk Factors and Treatments
Modern Medicine has assembled data on some of the emerging findings regarding AMD-associated risk factors and evolving treatment modalities for the disease.In addition, we highlight the banding together of the key professional ophthalmic societies in a...
|
|
|
UW Researchers Develop New Model for Macular Degeneration
(PhysOrg.com) -- Exposing albino rats to moderately intense light has produced a new animal model for the most common cause of severe vision loss in humans.The new model could help 'provide important new insights into the pathogenesis' of age-related ...
|
|
|
Progressive Eye Disease Affects Central Vision in Older Americans
INDIANAPOLIS?Indianapolis resident Harry Traugott was an active retiree, participating in community events, driving and even teaching English as a second language at two community centers? Hed been diagnosed with age-related macular degeneration (AMD...
|
|
|
Physician's Focus: Age-Related Macular Degeneration (AMD)—Risk Factors and Treatments
The National Eye Institute now cites age-related macular degeneration (AMD) as a leading cause of vision loss in Americans 60 years of age and older.Though age has long been identified as a leading AMD risk factor (one third of adults over age 75 are...
|
|
|
Age-related macular degeneration affects central vision in older Americans
Indianapolis resident Harry Traugott was an active retiree, participating in community events, driving and even teaching English as a second language at two community centers.Hed been diagnosed with age-related macular degeneration (AMD), but the...
|
|
|
High Resolution Fourier-Domain Optical Coherence Tomography of Choroidal Neovascular Membranes Associated with Age-Related Macular Degeneration
_ High Resolution Fourier-Domain Optical Coherence Tomography of Choroidal Neovascular Membranes Associated with Age-Related Macular Degeneration.
|
|
|
Complement, Age-Related Macular Degeneration and a Vision of the Future
_ Complement, Age-Related Macular Degeneration and a Vision of the Future.
|
|
|
Interferon Gamma-inducible Protein (IP-10) and Eotaxin Are Associated with Age-related Macular Degeneration
_ Interferon Gamma-inducible Protein (IP-10) and Eotaxin Are Associated with Age-related Macular Degeneration.
|
|
|
Sankara Eye Hospital teams up DWCD to screen 200 underprivileged women in Bangalore
Sankara Eye Hospital, Bangalore in association with Department of Women and Child Development (DWCD), government of Karnataka conducted an eye screening camp for underprivileged women.Over 200 women participated in the programme. Many numbers of women were...
|
|
|
Acute Corticospinal Tract Wallerian Degeneration Is Associated With Stroke Outcome
DeVetten G et al.CST ADC decreases after acute stroke in patients with poor motor outcome and may represent early Wallerian degeneration. Acute Corticospinal Tract Wallerian Degeneration Is Associated With Stroke Outcome.
|
|
|
Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity
Neurochem.(2010) 10.1111/j.1471-4159.2010.06622.x Degeneration of locus coeruleus (LC) noradrenergic forebrain projection neurons is an early feature of Alzheimer's disease. The physiological consequences of this phenomenon are unclear, but...
|
|
|
Are You At Risk For Age-Related Macular Degeneration (AMD)? Learn The Top 5 Risk Factors
Age-related macular degeneration (AMD) is a leading cause of severe vision loss among Americans ages 65 and over.Knowing your risk factors, being aware of your family history, and keeping regular appointments with your Eye M.D. can help reduce your...
|
|
|
Medical News: Are You At Risk For Age-Related Macular Degeneration (AMD)? Learn The Top 5 Risk Factors
Age-related macular degeneration (AMD) is a leading cause of severe vision loss among Americans ages 65 and over.Knowing your risk factors, being aware of your family history, and keeping regular appointments with your Eye M.D. can help reduce your...
|
|
|
Researchers develop vax to reverse Parkinson's disease
Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease.The findings appeared in the March 1 issue of the Journal of...
|
|
|
Are You at Risk for Age-Related Macular Degeneration (AMD)? Learn the Top 5 Risk Factors
SAN FRANCISCOAge-related macular degeneration (AMD) is a leading cause of severe vision loss among Americans ages 65 and over.Knowing your risk factors, being aware of your family history, and keeping regular appointments with your Eye M.D. can help...
|
|
|
RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age-related Macular Degeneration
The purpose of establishing the RheoNet registry was to evaluate the safety and efficacy of rheopheresis, a specific method of therapeutic apheresis used to treat microcirculatory disorders.Apheresis centers providing rheopheresis therapy and physicians...
|
|
|
Are You at Risk for Age-Related Macular Degeneration (AMD)? Learn the Top 5 Risk Factors
Companies mentioned in this article: American Academy of Ophthalmology SAN FRANCISCO, CA -- (Marketwire) -- 03/03/10 -- Age-related macular degeneration (AMD) is a leading cause of severe vision loss among Americans ages 65 and over.Knowing your risk...
|
|
|
Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt's Macular Dystrophy
"We are pleased that the FDA has, for the first time, granted orphan drug status for the use of an embryonic stem cell derived therapy in treating an unmet medical need," said Edmund Mickunas, Vice President Regulatory."We believe that our terminally...
|
|
|
Researchers Take Next Step In Developing Parkinson's Disease Vaccine
Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease.The findings appear in the March 1 issue of the Journal of...
|
|
|
UNMC takes next step in developing Parkinsons disease vaccine
Font size: Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinsons disease.The findings appear in the March 1 issue of the...
|
|
|
Researchers Take Next Step in Developing Parkinson's Disease Vaccine
Newswise Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease.The findings appear in the March 1 issue of the...
|
|
|
The Association Between Lumbar Disc Degeneration and Low Back Pain: The Influence of Age, Gender, and Individual Radiographic Features
de Schepper EIT et al.The authors are the first to report different possible lumbar disc degeneration definitions and their associations with LBP. The Association Between Lumbar Disc Degeneration and Low Back Pain: The Influence of Age, Gender, and...
|
|
|
Retinal injections, up close and in depth
By the time 2011 rolls around, retinal specialists are going to be confronted with a vexing situation.Data from a government-sponsored head-to-head comparison of some of the best treatments available for wet age-related macular degeneration (AMD)namely...
|
|
|
Radiation, injections reduce treatment burden for age-related macular degeneration
San Francisco?A preliminary study of epimacular brachytherapy showed that radiation and anti-vascular endothelial growth factor (VEGF) injections reduced the treatment burden and maintained the visual acuity (VA) in patients with neovascular age-related ...
|
